» Articles » PMID: 18330938

Apoptosis of Human Pancreatic Cancer Cells Induced by Triptolide

Overview
Specialty Gastroenterology
Date 2008 Mar 12
PMID 18330938
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate apoptosis in human pancreatic cancer cells induced by Triptolide (TL), and the relationship between this apoptosis and expression of caspase-3' bcl-2 and bax.

Methods: Human pancreatic cancer cell line SW1990 was cultured in DMEM media for this study. MTT assay was used to determine the cell growth inhibitory rate in vitro. Flow cytometry and TUNEL assay were used to detect the apoptosis of human pancreatic cancer cells before and after TL treatment. RT-PCR was used to detect the expression of apoptosis-associated gene caspase-3' bcl-2 and bax.

Results: TL inhibited the growth of human pancreatic cancer cells in a dose-and time-dependent manner. TL induced human pancreatic cancer cells to undergo apoptosis with typically apoptotic characteristics. TUNEL assay showed that after the treatment of human pancreatic cancer cells with 40 ng/mL TL for 12 h and 24 h, the apoptotic rates of human pancreatic cancer cells increased significantly. RT-PCR demonstrated that caspase-3 and bax were significantly up-regulated in SW1990 cells treated with TL while bcl-2 mRNA was not.

Conclusion: TL is able to induce the apoptosis in human pancreatic cancer cells. This apoptosis may be mediated by up-regulating the expression of apoptosis-associated caspase-3 and bax gene.

Citing Articles

A comprehensive review on phytochemicals in the treatment and prevention of pancreatic cancer: Focusing on their mechanism of action.

Arnab M, Islam M, Saydur Rahman M Health Sci Rep. 2024; 7(5):e2085.

PMID: 38690008 PMC: 11056788. DOI: 10.1002/hsr2.2085.


Apoptosis Triggering, an Important Way for Natural Products From Herbal Medicines to Treat Pancreatic Cancers.

Li M, Tang D, Yang T, Qian D, Xu R Front Pharmacol. 2022; 12:796300.

PMID: 35222011 PMC: 8863938. DOI: 10.3389/fphar.2021.796300.


Improved Antitumor Outcomes for Colon Cancer Using Nanomicelles Loaded with the Novel Antitumor Agent LA67.

Cui M, Jin M, Han M, Zang Y, Li C, Zhang D Int J Nanomedicine. 2020; 15:3563-3576.

PMID: 32547014 PMC: 7245463. DOI: 10.2147/IJN.S241577.


Natural Products and Synthetic Analogs as a Source of Antitumor Drugs.

Sharifi-Rad J, Ozleyen A, Tumer T, Oluwaseun Adetunji C, El Omari N, Balahbib A Biomolecules. 2019; 9(11).

PMID: 31683894 PMC: 6920853. DOI: 10.3390/biom9110679.


Triptolide inhibits proliferation, differentiation and induces apoptosis of osteoblastic MC3T3‑E1 cells.

Ji W, Liu S, Zhao X, Guo Y, Xia S, Lu Y Mol Med Rep. 2017; 16(5):7391-7397.

PMID: 28944904 PMC: 5865870. DOI: 10.3892/mmr.2017.7568.


References
1.
Parker S, Tong T, Bolden S, Wingo P . Cancer statistics, 1996. CA Cancer J Clin. 1996; 46(1):5-27. DOI: 10.3322/canjclin.46.1.5. View

2.
Ma J, Dey M, Yang H, Poulev A, Pouleva R, Dorn R . Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry. 2007; 68(8):1172-8. DOI: 10.1016/j.phytochem.2007.02.021. View

3.
Shamon L, Pezzuto J, GRAVES J, Mehta R, Wangcharoentrakul S, Sangsuwan R . Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett. 1997; 112(1):113-7. DOI: 10.1016/S0304-3835(96)04554-5. View

4.
Lee K, Park J, Jee Y, Rosen G . Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation. Exp Mol Med. 2003; 34(6):462-8. DOI: 10.1038/emm.2002.64. View

5.
Yang S, Chen J, Guo Z, Xu X, Wang L, Pei X . Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther. 2003; 2(1):65-72. View